about
Human cytidine deaminase APOBEC3H restricts HIV-1 replicationStructural and Functional Study of Apoptosis-linked Gene-2·Heme-binding Protein 2 Interactions in HIV-1 ProductionDemonstration of a novel HIV-1 restriction phenotype from a human T cell lineIdentification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey.Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity.Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycleEquine Infectious Anemia Virus Gag Assembly and Export Are Directed by Matrix Protein through trans-Golgi Networks and Cellular Vesicles.Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.Comprehensive analysis of the overall codon usage patterns in equine infectious anemia virus.Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.Clues for two-step virion infectivity factor regulation by core binding factor beta.Regulation of Rev expression by the equine infectious anaemia virus tat-rev mRNA Kozak sequence and its potential influence on viral replication.Similar regulation of two distinct UL24 promoters by regulatory proteins of equine herpesvirus type 1 (EHV-1).Development of a single-tube duplex EvaGreen real-time PCR for the detection and identification of EHV-1 and EHV-4.Inhibition of virus replication and induction of human tetherin gene expression by equine IFN-α1.Genetic analysis of the PB1-F2 gene of equine influenza virus.Optimization and application of a DNA-launched infectious clone of equine arteritis virus.Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.Development of an antigen-capture ELISA for the quantitation of equine arteritis virus in culture supernatant.Strain-Specific Antagonism of the Human H1N1 Influenza A Virus against Equine Tetherin.Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid ProteinA unique feature of swine ANP32A provides susceptibility to avian influenza virus infection in pigsEquine Influenza Virus in Asia: Phylogeographic Pattern and Molecular Features Reveal Circulation of an Autochthonous LineageCharacterization of EIAV env Quasispecies during Long-Term Passage In Vitro: Gradual Loss of PathogenicityHigh-Efficiency Rescue of Equine Infectious Anemia Virus from a CMV-Driven Infectious CloneAttenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to ApoptosisANP32A and ANP32B are key factors in the Rev-dependent CRM1 pathway for nuclear export of HIV-1 unspliced mRNAFundamental Contribution and Host Range Determination of ANP32A and ANP32B in Influenza A Virus Polymerase ActivityEnv diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine
P50
Q24653682-597082E7-42D6-4DBE-B5A9-E3E2AFE57F33Q28975761-F15066D0-5F65-40DB-9870-2CF15910846AQ33355942-4880827C-BD3E-4DB1-B556-FBE71023F97EQ34055413-0850246D-1B0B-48BB-A46A-266020A54566Q34123690-C2ED936B-F484-4995-8443-5B4DC8699A17Q35668775-D92806E1-B127-4E3C-841A-DFB2E2903910Q35819383-AA3DF75C-3A4B-4BD0-A044-0262CE38EB86Q36524040-5C621C72-79AE-4E12-BF35-C2847727D1CDQ37333725-A1BA592D-7DF9-4FA2-B347-1ABEAD87E99EQ37425748-D8C1628F-EE1E-412B-8517-B7129BD85288Q37547504-09C6C740-005B-49FA-9459-619B5BEA7A3FQ38703114-66EC34CD-933B-4957-95A3-62798A1450C1Q38758346-6D8C2164-A013-4F57-A0C4-AF6A3E271F3DQ38879541-57A3A00A-B565-4AC3-B54B-1F5F7EFDF716Q42232483-F228DE4E-76C0-4C17-8D3A-4D3A992DF6BEQ42243469-A6049A31-C2FB-4ABC-A37A-6B84E742A417Q44465914-208F8EF2-634C-4499-8EEB-4F19E0CD2D53Q45324880-3DB0C3C3-FD1A-4B29-87F6-5B4D4FF9073EQ45387486-4EC17550-CF00-481D-ACB1-AD5565156C31Q50045556-F5B4ABFA-24FD-40DD-A0CD-9874C35E3F79Q55096711-7C6AEBC5-180F-4EDA-BC2B-75F71EEA8B75Q58693128-51EE0846-CC8B-431C-B855-3543DD3EF542Q89831108-818D1847-51F7-45DE-B548-46E121873EEFQ90282552-E386E2B4-ABA8-4267-B1FF-8323CEC5A382Q91515399-B0EE9278-2D5B-49FE-8D7D-5D5FBC92F9DAQ92379745-DA49D060-DBE7-4750-957A-43FE88CD1E42Q92482114-15B27B9B-B21E-42F0-A90C-14B7B851B8CEQ92831817-D7BEF6A1-34A5-4E33-BB44-0B61F819FD2AQ93161927-07579636-F293-4582-A310-957186881AA8Q96290668-C763A692-8A21-4B4A-9683-D7DDB9AEBAC3
P50
description
researcher (ORCID 0000-0003-4521-4099)
@en
name
Xiaojun Wang
@en
Xiaojun Wang
@nl
type
label
Xiaojun Wang
@en
Xiaojun Wang
@nl
prefLabel
Xiaojun Wang
@en
Xiaojun Wang
@nl
P31
P496
0000-0003-4521-4099